In our study, in line with the literature, KIT variants were detected in 3.88% and CDKN2A variants in 2.91% of our MM patients, and these variations were more commonly observed in metastatic geriatric patients. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.